Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used class of antidepressant drugs, but the cellular and molecular mechanisms by which their therapeutic action is initiated are poorly understood. Here we show that serotonin 5-HT1B receptors in cholecystokinin (CCK) inhibitory interneurons of the mammalian dentate gyrus (DG) initiate the therapeutic response to antidepressants. In these neurons, 5-HT1B receptors are expressed presynaptically, and their activation inhibits GABA release. Inhibition of GABA release from CCK neurons disinhibits parvalbumin (PV) interneurons and, as a consequence, reduces the neuronal activity of the granule cells. Finally, inhibition of CCK neurons mimics the antidepressant behavioral effects of SSRIs, suggesting that these cells may represent a novel cellular target for the development of fastacting antidepressant drugs.
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In Brief Medrihan et al. show that the initial behavioral improvement induced by SSRIs in the DG starts with the inhibition of CCK neurons, which leads to a disinhibition of PV neurons and a reduced excitability of granule cells.
INTRODUCTION
Major depressive disorder (MDD) represents a substantial global burden, reportedly affecting 7% of the world population and 16% of the United States population (Levinstein and Samuels, 2014) . The most common and effective drugs used for the treatment of MDD are the selective serotonin (5-hydroxytryptamine [5-HT]) reuptake inhibitors (SSRIs), which act primarily by blocking the reuptake of 5-HT from the synaptic cleft into the presynaptic serotonergic nerve terminals, thereby increasing serotonergic transmission Trivedi et al., 2006) . 5-HT can activate seven families of 5-HT receptors (5-HTRs) comprising 14 isoforms that are present in various combinations in different neuronal types. With the exception of the ionotropic 5-HT3, all 5-HTRs are metabotropic, coupled to diverse G protein effectors, and have excitatory or inhibitory actions in different cell types (Hannon and Hoyer, 2008) . SSRI treatment suffers from a variety of drawbacks, most notably a delay in the onset of therapeutic action (Quitkin et al., 1984) . Although the SSRIs have an immediate pharmacological action, they reach their full antidepressant effect in patients with a considerable delay, from weeks to months (Krishnan and Nestler, 2008) . Recent analyses of antidepressant response to SSRIs have revealed early signs of clinical improvement (Posternak and Zimmerman, 2005; Taylor et al., 2006) . Moreover, early improvement correlated well with the prediction of a complete functional remission by antidepressant treatment (Nierenberg et al., 2000; Stassen et al., 1996) . Still, the lack of knowledge concerning the cellular and molecular targets of the SSRI response remains a major gap in MDD therapy.
The dentate gyrus (DG), a major target of serotonergic innervation (Leranth and Hajszan, 2007) , has been implicated in the response to SSRIs. SSRI treatment promotes a variety of synaptic, cellular, and network adaptations in the DG (Santarelli et al., 2003; Shirayama et al., 2002) . Moreover, 5-HT1ARs on granule cells have recently been reported as essential for the chronic response to fluoxetine (Samuels et al., 2015) . However, little is known about the 5-HTR isoforms expressed in the various cell types in the DG and their contribution to the action of SSRIs.
The activity of the granule cells is under the tight control of two classes of perisomatic GABAergic interneurons, parvalbumin (PV)-expressing and cholecystokinin (CCK)-expressing neurons. PV interneurons are fast-spiking neurons with high glutamatergic input that modulate feedforward inhibition and control thetagamma oscillations, essential mechanisms for the processing functions of the DG (Hu et al., 2014) . CCK interneurons are regular-spiking neurons that are mainly involved in feedback inhibition. Unlike PV neurons, CCK neurons are highly modulated by neurotransmitter systems associated with mood disorders, including the serotonergic and the cholinergic systems (Armstrong and Soltesz, 2012; Bartos and Elgueta, 2012) . DG CCK neurons are innervated by fibers from serotonergic cells of the raphe nucleus (Leranth and Hajszan, 2007) , but how 5-HT and SSRIs modulate the function of CCK neurons and how they are involved in the antidepressant response are unknown.
RESULTS

5-HTRs on CCK Neurons Mediate Acute and Chronic Antidepressant Responses
To identify the 5-HTR isoforms that are present on CCK hippocampal neurons, we used a translating ribosome affinity purification (TRAP) approach, and we generated CCK-TRAP conditional (legend continued on next page) knockin mice. To this end, we used mice bearing a loxPstop-loxP-EGFP-RPL10a sequence in the Eef1a1 promoter (EEF1A1-LSL.EGFPL10) (Stanley et al., 2013) , and we crossed them with CCKCre mice. We validated the specificity and functionality of the EGFP/RPL10a fusion protein in CCK-expressing cells of the hippocampus (Figures 1A and 1B) . Translational profiling analysis revealed that CCK neurons express transcripts of five 5-HTR proteins: 5-HT1B, 5-HT2A, 5-HT2C, 5-HT3a, and 5-HT5B. Among these, the mRNA levels of 5-HT1B, 5-HT2A, and 5-HT5B receptors were highly expressed in CCK cells relative to the unbound fraction, which represented all hippocampal cells, and they were highly abundant compared to the other 5-HTRs ( Figure 1C ). 5-HT3A receptor (5-HT3AR), previously shown to be expressed in these cells (Tanaka et al., 2012) , was enriched in CCK cells, but its level was very low ( Figure 1C ). We further confirmed the protein co-expression of 5-HT1B, 5-HT2A, and 5-HT5B receptors in DG CCK neurons by immunohistochemistry ( Figure 1D ).
We next studied the behavioral impact of these receptors in CCK cells. To this end, we generated transgenic mice with conditional deletions of 5-HT1B (5-HT1B conditional knockout [cKO]), 5-HT2A (5-HT2A cKO), or 5-HT5B (5-HT5B cKO) receptors from CCK cells, and we examined their hedonic and depressive-like behavior in the sucrose preference test (SPT), forced swim test (FST), tail suspension test (TST), and novelty suppressed feeding test (NSF). None of the genotypes manifested anhedonia ( Figure 1E ) or depressive-like behavior ( Figures 1F-1J ). We next tested the behavioral response to the SSRI antidepressants fluoxetine (Flx) or citalopram (CIT) in two types of regimens. In the acute response, animals were tested 15 min after receiving one intraperitoneal injection of the SSRI. The chronic regimen consisted of 18 days of treatment and ended 1 day before the behavioral tests. Flx was consumed in the drinking water , whereas CIT was intraperitoneally injected. Acute administration of SSRIs reduced the immobility of wild-type (WT) and 5-HT2A and 5-HT5B cKO mice in both the FST ( Figure 1F ) and the TST ( Figure 1G ), but it did not reduce the immobility of 5-HT1B cKOs in either test (Figures 1F and 1G) . On the contrary, chronic SSRI treatment markedly reduced the immobility of WT, 5-HT1B cKO, and 5-HT5B cKO mice in the FST ( Figure 1H ) and of WT and 5-HT5B mice in the TST ( Figure 1I ), but it failed to induce an improvement in 5-HT2A cKOs in either test (Figures 1H and 1I) .
We next tested the effect of chronic Flx treatment on the latency to approach a food pellet in the NSF. This test has been used to measure the beneficial effects of chronic antidepressant treatment in the DG (Santarelli et al., 2003) . Chronic Flx treatment reduced the latency to approach the food pellet of WT and 5-HT1B and 5-HT5B cKO mice, but not that of 5-HT2A cKOs ( Figure 1J ), consistent with the idea that 5-HT2A receptors (5-HT2ARs) are essential for the delayed antidepressant response.
Transcriptional Downregulation of 5-HT2AR Is Associated with the Behavioral Response to Chronic SSRI Treatment We next measured the response to 5-HT in DG CCK neurons by performing whole-cell patch-clamp recordings in hippocampal slices. Application of 30 mM 5-HT produced a hyperpolarizing effect on the membrane potential of CCK neurons (Figures 2A and  2B ; Figure S1A ), which was completely blocked by pre-incubation of the slices with ketanserin (Ket, antagonist of 5-HT2AR), suggesting that 5-HT2AR activation is sufficient to mediate the observed hyperpolarizing response (Figures 2A and 2B ). However, in slices from mice chronically treated with Flx, the response to 5-HT was greatly reduced (Figures 2A and 2B ).
In line with the literature (McCorvy and Roth, 2015) , we confirmed that 5-HT2ARs are Gq-coupled by blocking the response to 5-HT with wortmannin (Figures S1B and S1C). CCK neurons express the 1/2/3 subunits of G protein-coupled (B) Bar graph summary of enrichment of mRNA level of the CCK gene in EGFP/L10a-expressing cells (immunoprecipitation [IP] ) and in the respective unbound fraction of the hippocampal lysate (57.0 ± 6.70 and 19.2 ± 4.88 of gapdh, respectively). The level of the PV gene (pvalb) is depleted in CCK cells (0.2% ± 0.11% in the immunoprecipitated and 0.9% ± 0.32% of gapdh in the unbound). Bars represent means ± SD (*p = 0.018 and ***p = 0.0002 by two-tailed paired t test; n = 5 samples). (C) Scatterplot summary of the mRNA levels of 5-HTRs in CCK neurons as percentage of those in the unbound fraction of the lysate (y axis) or as percentage of gapdh (x axis) (*p < 0.05 and ***p < 0.001 versus unbound by two-tailed paired t test; n = 5 samples). Data represent means ± SD. (D) Representative immunolabeling images for the three 5-HTRs that met the criteria of specificity and abundance in CCK DG neurons. Scale bar, 50 mm. (E) Dot plot analysis of sucrose preference test (SPT). Bottles with 2% sucrose and water were weighed after 48 hr of the test of WT mice (n = 9), 5-HT1B cKO (n = 8), 5HT2A cKO (n = 9), or 5HT5B cKO (n = 8). Bars represent means ± SEM (one-Way ANOVA, F (3, 30) = 0.51, p > 0.05). (F) Bar graph summary of immobility time in the forced swim test (FST) 15 min after acute injection of vehicle (Veh) or fluoxetine (Flx) in WT mice (n = 10 Veh and 12 Flx, written as n = 10, 12), 5-HT1B cKO (n = 9, 11), 5-HT2A cKO (n = 10, 10), or 5HT5B cKO (n = 10, 9). Bars represent means ± SEM (two-way ANOVA, F genotype X treatment [3, 73] = 9.91, p < 0.0001; **p < 0.01 and *p < 0.05 versus Veh by post hoc Bonferroni). (G) Bar graph summary of immobility time in the tail suspension test (TST) 15 min after acute injection of saline (Veh) or citalopram (CIT) in WT mice (n = 7, 7), 5-HT1B cKO (n = 7, 7), 5-HT2A cKO (n = 7, 7), or 5-HT5B cKO (n = 5, 5). Bars represent means ± SEM (two-way ANOVA, F genotype X treatment [3, 44] = 7.07, p < 0.001; **p < 0.01 and ***p < 0.001 versus Veh by post hoc Bonferroni). (H) Bar graph summary of immobility time in the FST after drinking saccharine alone (Veh) or fluoxetine/saccharine mixture (Flx) for 18 days in WT (n = 10, 13), 5HT1B cKO (n = 10, 12), 5-HT2A cKO (n = 12, 10), or 5-HT5B cKO (n = 9, 10). Bars represent means ± SEM (two-way ANOVA, F genotype X treatment [3, 78] inwardly rectifying potassium (GIRK) channels, a likely effector of the Gq-signaling pathway ( Figure S1D ). Indeed, CCK neurons showed a hyperpolarizing potassium current that was significantly increased by 5-HT and was attenuated by Ba 2+ , a blocker of the GIRK channels ( Figure 2C ). In slices from Flx-treated mice, application of 5-HT failed to induce a significant increase in the hyperpolarizing potassium current ( Figure 2D ), suggesting that GIRK channels are the downstream effector of 5-HT2ARs and that these receptors are downregulated by chronic Flx treatment. To test this directly, we used 2,5-Dimethoxy-4-iodoamphetamine hydrochloride (DOI) hydrochloride, an agonist of the 5-HT2ARs. DOI induced a robust current response in CCK neurons that was abolished after chronic Flx treatment ( Figure 2E) . Immunofluorescence experiments confirmed a reduction in the fraction of DG CCK neurons immunopositive for 5-HT2A after chronic Flx treatment (Figures 2F and 2G) . In line with this, qPCR analysis of TRAP samples revealed a reduction in 5-HT2A mRNA level in hippocampal CCK neurons after chronic Flx treatment relative to that in the vehicle group. A reduction was also detected in 5-HT1B and 5-HT5B mRNA levels, suggesting that these 5-HTRs are transcriptionally downregulated by SSRIs ( Figure 2H ). p11 in CCK Neurons of the Ventral DG Mediates the Acute Behavioral Response to Antidepressants Our previous work showed that the function of the 5-HT1B receptor (5-HT1BR) is dependent on p11 (the protein product of the gene S100A10) and that the interaction between the 5-HT1BR and p11 is functionally relevant both for occluding depressivelike behavior and for the antidepressant response (Svenningsson et al., 2006; Virk et al., 2016) . p11 was found to be highly enriched in CCK neurons (Egeland et al., 2010) . Constitutive deletion of p11 results in both depressive-like behavior and a loss of antidepressant response (Egeland et al., 2010; Svenningsson et al., 2006) . In contrast, specific deletion of p11 in cholinergic neurons of the nucleus accumbens leads to a depressive-and anhedoniclike phenotype, but it does not impair the response to antidepressant drugs .
We next tested the behavioral impact of p11 deletion specifically from CCK neurons. p11 cKO mice did not show depressive-like behavior in the TST or FST ( Figures 3A and 3B ). We previously found that p11 interacts with 5-HT1B, 5-HT1D, and 5-HT4 receptors (Svenningsson et al., 2006; Warner-Schmidt et al., 2009 ). Removing p11 from CCK neurons led to a loss of the acute response to antidepressant drugs that target the serotonergic system, but the response to the noradrenergic and serotonergic agent mirtazapine was normal (Figures 3A and 3B) , suggesting that p11 specifically initiates the response to SSRIs in CCK cells. To validate the role of p11 in CCK cells of the DG, the behavioral response to Flx was studied in CCK p11 cKO mice in which p11 levels were restored in CCK cells in the DG. To this end, we delivered AAV expressing a Credependent construct of p11 to CCK-immunopositive cells of the ventral DG (DGv; Figure 3C ). Reintroducing p11 in mature CCK cells of the DGv restored the Flx response in the FST paradigm ( Figure 3D ). Finally, to study the effect of induction of p11 levels in WT DG CCK cells on the behavioral response to Flx, mice were tested after the transduction of p11 or YFP into CCK cells of the DGv. As expected, WT mice injected with either gene responded similarly to Flx ( Figure 3E ).
5-HT1BRs Inhibit GABA Release from CCK Neurons and Modulate the Spiking Activity of DG Neurons
We next studied the role of the 5-HT1BR in mediating the response to acute SSRI treatment in CCK neurons. 5-HT1BRs are expressed in axon terminals (Boschert et al., 1994) , and, as expected, bath application of a 5-HT1BR agonist (CP93129, 10 mM) failed to induce a noticeable change in the CCK membrane potential ( Figure S2A ). We next studied how GABA release from CCK neurons onto granule cells (GCs) is modulated by 5-HT1BR. To this end, we performed paired recordings from these two types of cells since it has been shown that these two neurons are monosynaptically connected (Hefft and Jonas, 2005) . Unitary GABAergic postsynaptic currents were evoked in GCs by brief (1-2 ms) current injections into presynaptic CCK neurons in the presence of glutamate receptor blockers. To (A and B) Current-clamp traces (A) and statistical data (B) from whole-cell patch-clamped CCK neurons in the dentate gyrus. Bath application of 30 mM 5-HT led to a hyperpolarization of the membrane potential (À5.02 ± 1.2 mV, n = 6 neurons/4 mice), but not when the slices were previously incubated with the 5-HT2AR antagonist ketanserin (Ket, 20 mM) (À0.86 ± 0.13 mV, n = 3/2) or after the mice were treated with fluoxetine (Flx) for 18 days (1.50 ± 0.3, n = 7/3) (one-way ANOVA, F [2, 13] = 6.29, p = 0.012; *p < 0.05 versus control by post hoc Bonferroni). In (B), data represent means ± SEM. (C) Representative traces of inward GIRK-mediated potassium currents (left) evoked with 10-mV potential steps from À140 to À40 mV in control mice and their corresponding I-V curves (right). Bath application of 30 mM 5-HT significantly increased the maximum inward K + current (from 358.7 ± 34.1 pA, n = 13/5 to 603.3 ± 90.3 pA, n = 6/3), and the current was abolished by the successive application of 300 mM Ba confirm the presynaptic site of action of 5-HT1BR, we used a paired-pulse protocol in all experiments ( Figure 4A ). We observed that the amplitude of the unitary GABA response was increased by the addition of GR55562 (10 mM), a blocker of 5-HT1BR ( Figure 4B ). In line with the literature (Hefft and Jonas, 2005) , CCK-GC synapses showed synaptic depression in the paired-pulse protocol, and blocking 5-HT1BR further enhanced the synaptic depression, suggesting that these receptors have a presynaptic inhibitory role on the GABAergic output from CCK neurons ( Figure 4C ). In the 5-HT1B cKO mice, the addition of GR55562 did not change the amplitude of the first response or the paired-pulse ratio in the same experimental paradigm (Figures 4D and 4E) . Importantly, paired recordings from p11 cKO mice showed that the addition of GR55562 did not change the amplitude of the first response or the paired-pulse ratio, suggesting that, in the absence of p11, 5-HT1BRs in CCK neurons are not functional (Figures 4F and 4G) . In contrast, the deletion of p11 from CCK neurons did not influence the response to 5-HT mediated by 5-HT2AR ( Figures S3B and S3C) . Moreover, the electrical properties of the neurons ( Figures S3D-S3M ) and the GABA/glutamate responses of these cells ( Figures S2E-S2H) were not changed in the p11 cKO mice. We further confirmed the paired recording results in all three genotypes by measuring the miniature inhibitory postsynaptic currents (mIPSCs) in GCs, since it has been shown that the majority of mIPSCs recorded in GCs are generated by CCK neurons (Goswami et al., 2012) 
To investigate a possible molecular mechanism for the regulation of 5-HT1BR function by p11, we used TRAP analysis. In agreement with our previous studies showing that p11 regulates the function, but not the level, of 5-HT1BR (Svenningsson et al., 2006; Virk et al., 2016) , we found that the translated mRNA level of 5-HT1BR in CCK cells was unchanged in the hippocampus from p11 cKO mice ( Figure S3A ).
It seems likely that the modulation of GABA release from CCK neurons by 5-HT1BR would induce noticeable changes in the DG network activity. To test this hypothesis, we performed in vivo local field potential (LFP) recordings in the DG of urethane-anesthetized mice ( Figure 4H ; Figure S4A ). We first measured the action potential (spike) frequency in the DG, and we did not notice any difference among WT, 5-HT2A cKO, 5-HT1B cKO, and p11 cKO mice ( Figure 4I ). Moreover, an acute injection with Flx (7.5 mg/kg) did not induce significant changes in spike frequency in any of the tested genotypes ( Figure 4I ). Flx injection did not alter the overall power spectral density, which was severely decreased at all frequencies in the 5-HT2A cKO, 5-HT1B cKO, and p11 cKO mice compared to the WT mice (Figures S4B-S4E ). Since we wanted to explore how Flx affects the activity of the different neuronal populations of the DG, we isolated, based on the width of the waveform, the narrow spikes (coming from putative fast-spiking PV neurons) from the rest of the other spikes (coming from the remaining inhibitory and excitatory neurons) ( Figure 4J ). The ratio between the narrow waveform and the total number of spikes was significantly increased by the Flx injection only in WT and 5-HT2A cKO mice, but not in 5-HT1B cKO or p11 cKO mice ( Figure 4K ). These results suggest that presynaptic modulation of GABA release from CCK neurons by 5-HT1BRs changes directly the activity of putative PV DG neurons.
Chemogenetic Inhibition of CCK Neurons Reorganizes Neuronal Firing in the DG
In addition to the direct inhibition of CCK neurons, Flx has been shown to change the activity of other DG neurons that express 5-HTRs, for example, GCs (Samuels et al., 2015) . To test whether the increased activity of PV neurons by Flx is a direct result of the acute inhibition of CCK neurons, we utilized a combination of chemogenetics and in vivo high-density silicon-probe recordings. We injected Gi-coupled designer receptors exclusively activated by designer drugs (DREADD) viruses (hM4Di) into CCK cells of the DGv ( Figure 5A ; Figures S5A-S5D) , and we recorded the firing of defined neuronal populations after an acute intraperitoneal injection of Clozapine-N-oxide (CNO, 1 mg/kg), the ligand of the Gi DREADD receptor. Gi DREADD inhibits both presynaptic and postsynaptic components of the target cells (Roth, 2016) , thus mimicking the inhibitory effects of 5-HT/SSRIs through both 5-HT1B and 5-HT2ARs in CCK neurons.
Neurons were classified on the basis of the waveform features of their spikes ( Figure 5B ; see the Supplemental Experimental Procedures) into narrow and wide waveform neurons to separate putative fast-spiking PV-positive neurons from other cell classes in the hippocampus (Stark et al., 2013) . Analysis of bursting, a marker of internal firing dynamics that distinguishes wide waveform putative excitatory from inhibitory neurons in the DG (Senzai and Buzsá ki, 2017), further confirmed our classification. Almost half of the wide waveform neurons (but none of the narrow waveform neurons) showed bursts ( Figures S5E and S5F) , which confirmed that the latter group may represent putative fast-spiking interneurons (Puig et al., 2008) . All the neurons that were inhibited by the injection of CNO (firing rate decreased by more than 20% after injection) had wide waveforms, and, within this group, we could further separate them into bursty neurons, corresponding to GCs (Pernía-Andrade and Jonas, 2014; Senzai and Buzsá ki, 2017), or non-bursty neurons (Figure 5C ). Interestingly, non-bursty wide waveform neurons all had long refractory periods, a common characteristic of interneurons, and narrower waveforms than bursty neurons, as reported for CCK interneurons (Varga et al., 2015) . The inhibition of CCK-positive interneurons with CNO led to a significant increase in firing rate in the narrow waveform neurons ( Figure 5C , right panels), and the difference between pre-and post-CNO firing rates was significantly higher for narrow than wide waveform neurons ( Figure 5D ). These data suggest that the inhibition of DG CCK neurons alone is sufficient for a disinhibitory effect on putative PV neurons.
Inhibition of CCK Neurons Disinhibits PV Neurons and Induces Antidepressant Behavior
Our in vivo analysis suggested that the inhibition of DG CCK neurons, although not changing the total frequency of spikes in the DG, would favor a higher spiking frequency for fast-spiking interneurons to the detriment of other neuronal types. To confirm this, we next tested, in hippocampal slices, the changes in the firing of morphologically and physiologically identified GCs and PV interneurons ( Figures S6A-S6F ) induced by the inhibition of CCK neurons with CNO. Bath addition of CNO (1 mM) significantly increased the firing frequency of the PV cells ( Figures 6A and  6B ). The firing frequency of GCs was reduced by CNO ( Figures  6A and 6B ), presumably due to the increased activity of the inhibitory PV neurons. We further confirmed this effect by using optogenetics, and we showed that halorhodopsin-mediated inhibition of CCK neurons reduces the inhibitory input on PV neurons but increases the net inhibitory input on GCs ( Figures S6G-S6K ), probably due to the disinhibitory effect on PV cells. To investigate whether the inhibition of DG CCK neurons might cause a behavioral response, we tested mice injected bilaterally with the Gi-DREADD virus into CCK cells of the DGv ( Figure 6C ). CNO administration led to a significant reduction in the immobility of mice in the FST paradigm ( Figure 6D ). Moreover, acute treatment with Flx did not induce additional improvements in the behavior of these mice ( Figure 6D ), strongly supporting the idea that inhibition of CCK DGv neurons is sufficient for initiating the beneficial response to antidepressants.
DISCUSSION
Our data describe two distinct mechanisms of SSRI action dependent on different 5-HTRs expressed by CCK neurons, one that mediates the initiation of the physiological and behavioral responses and another that mediates the delayed component of these responses. Recent studies reported distinct 5-HTRs on specific neurons involved in the chronic response to antidepressants (Samuels et al., 2015; Schmidt et al., 2012) . We show here that CCK neurons in the DG are essential for the initial SSRI response, and we describe the functional changes in the DG microcircuit associated with this response.
Distinct 5-HTR Isoforms on CCK Neurons Mediate Acute and Chronic Antidepressant Responses 5-HT1BRs are present in several brain regions associated with anxiety and depressive illnesses, including the hippocampus, nucleus accumbens, dorsal raphe, cingulate cortex, and amygdala (Boschert et al., 1994; Carr and Lucki, 2011; Hannon and Hoyer, 2008) . These receptors are localized on axonal terminals, and they function either as autoreceptors in dorsal raphe projections, controlling 5-HT release, or as heteroreceptors, modulating the release of other neurotransmitters (Hannon and Hoyer, 2008) . Targeting 5-HT1BRs globally in mice decreases anxiety, but it does not affect depression-like behaviors (Brunner et al., 1999) . Our current and previous work emphasizes specific roles of the 5-HT1BR as a heteroreceptor in different neuronal populations. While deletion of 5-HT1BR from CCK neurons resulted in the loss of response to acute SSRIs, these mice do not show depressive-or anhedonic-like phenotypes. In contrast, the deletion of 5-HT1BR from cholinergic neurons leads to anhedonic-like behavior (Virk et al., 2016) . The function of 5-HT1BRs depends on p11, a protein that interacts with these receptors and is highly implicated in depression and response to SSRIs (Svenningsson et al., 2006 (Svenningsson et al., , 2013 (Svenningsson et al., , 2014 . We found that mice with conditional deletions of either p11 or 5-HT1BR display similar behavioral phenotypes. Deletion of p11 from cholinergic neurons led to depressive-and anhedonic-like behaviors, but it had no effects on the behavioral response to SSRIs (Warner- Schmidt et al., 2012) , whereas its deletion from CCK neurons affected the response to SSRIs, but not hedonic and helplessness behaviors. Interestingly, reintroduction of p11 into CCK cells in the ventral hippocampus rescued the antidepressant response to SSRIs.
(C) The ratio between the second and the first pulses in a 100-ms-interval paired-pulse protocol decreased from 0.68 ± 0.01 in the absence of GR 127935 to 0.52 ± 0.01 in the presence of GR 127935 (four pairs each, **p < 0.01, two-tailed unpaired t test). Data represent means ± SEM. (I) The spike frequency was not significantly different among genotypes or after a Flx (7.5 mg/kg) injection in the DG of WT (black, 3.39 ± 1.9 versus 3.24 ± 2.2 Hz), 5-HT2A cKO (green, 2.36 ± 1.2 versus 2.48 ± 1.7 Hz), 5-HT1B cKO (red, 1.93 ± 1.3 versus 2.32 ± 1.8 Hz), and p11 cKO (blue, 1.99 ± 1.2 versus 1.97 ± 1.7 Hz) mice (n = 6-11 mice per genotype). Bars represent means ± SEM. (J) A representative recording from a WT mouse that shows individual spikes classified by their half-width and their through-to-peak width in narrow waveform spikes (NW). Each dot represents a spike. (K) Before and after graphs showing the effect of a Flx (7.5 mg/kg) injection on the ratio between the narrow waveform spikes and the total number of spikes in the DG of WT (black), 5-HT2A cKO (green), 5-HT1B cKO (red), and p11 cKO (blue) mice. Each dot represents the ratio from one recorded animal (*p < 0.05, Wilcoxon matched-pair test).
We show here that the initial presence of 5-HT2ARs in DG CCK neurons is essential for the behavioral response to chronic SSRIs. Interestingly, the behavioral action of antidepressants appears to require a reduction in 5-HT2ARs: chronic treatment with tricyclic antidepressants, monoamine inhibitors, and some SSRIs results in the downregulation of brain 5-HT2AR density (Gray and Roth, 2001; Van Oekelen et al., 2003) . 5-HT2A antagonists produce an antidepressant-like effect (Pehek et al., 2006) , and selective blockade of 5-HT2AR in patients enhances the Flx response (Marek et al., 2005) . Chronic treatment with Flx results in the downregulation of 5-HT2AR mRNA and protein levels in CCK neurons and, as a consequence, in a decrease of the inhibitory current that this receptor mediates. In addition to 5-HT2A, both 5-HT1B and 5-HT5B receptors, which are highly expressed in CCK cells, were transcriptionally downregulated after chronic SSRI treatment. Our data strongly suggest that an initial response to SSRI, followed by the transcriptional downregulation of multiple presynaptic and postsynaptic 5-HTRs, is required for the highly sensitive response of CCK cells to SSRIs.
In addition to 5-HT1B and 5-HT2ARs, our data show that 5-HT5B receptor (5-HT5BR) is highly expressed and transcriptionally regulated by SSRIs in CCK neurons, but we could not detect a functional role for this receptor in spite of its high abundance in these cells. Interestingly, 5-HT5BR becomes a pseudogene in primates and cannot be a therapeutic target in MDD (Hannon and Hoyer, 2008) . Using TRAP we also confirmed the expression of mRNA for 5-HT3AR, a receptor previously implicated in hippocampal CCK neuron function (Morales and Bloom, 1997) . Our molecular and functional data suggest that the expression level of 5-HT3AR in CCK DG cells is too low to mediate a significant response to 5-HT. Our collective data strongly suggest that 5-HT2A and 5-HT1BRs are the major targets of 5-HT and SSRIs in these cells. Interestingly, new studies link variations in the human 5-HT2AR gene with the outcome of . For each cell, the left panel shows the spiking auto-correlogram, and the right panel shows the average firing rates in intervals of 5 min before and after CNO injection. p1, peaky (but non-bursty) auto-correlogram, wide waveform neuron; b1, bursty wide waveform neuron; nb1-2, non-bursty wide waveform neurons; n1-2, narrow waveform neurons. Horizontal and vertical scale bars represent 1 ms and 25 mV, respectively. (D) Cumulative distribution of the firing rate ratios before and after CNO injection (in base 10 log values) (p = 0.0079, Mann-Whitney U test; n = 62 and 12 wide and narrow waveform neurons, respectively). the antidepressant response (McMahon et al., 2006) , and they identify a possible association between a locus in the mouse 5-HT1BR gene and anxiety behavior in mice (Nicod et al., 2016) .
Inhibition of CCK Neurons Induces an Acute Antidepressant Response through the Disinhibition of PV Neurons
Acute SSRI treatment induces an immediate antidepressant effect in rodents. However, even though some immediate positive effects have been noticed in patients, these drugs reach their full antidepressant effect only after a considerable delay (Krishnan and Nestler, 2008) . Our results show that acute antidepressant effects are dependent on 5-HT1BR in CCK neurons, suggesting that a cell-type-specific and 5-HTR isoform-specific approach may enable the identification of fast-acting antidepressants. 5-HT2A and 5-HT1BRs act synergistically by inhibiting the firing of CCK neurons and presynaptic GABA release, yet only 5-HT1B seems to be essential for the acute antidepressant effect. One possible explanation may be that CCK DG cells are innervated by serotonergic fibers from the dorsal raphe nuclei that tend to be thin axons with small varicosities and rely on volume transmission, releasing 5-HT diffusely at non-synaptic sites (Leranth and Hajszan, 2007) . A second explanation may be that 5-HT2ARs are inactivated quickly after exposure to an agonist, either through desensitization mediated by protein kinase C (PKC) (Roth et al., 1995) and/or by internalization of the receptors (Berry et al., 1996) . Thus, SSRI-induced availability of 5-HT in the proximity of CCK neurons will tend to activate 5-HT1BRs, which in turn will act by inhibiting GABA release from CCK neurons.
Surprisingly, the inhibition of GABA release from CCK neurons by Gi-DREADD did not lead to the expected increased firing of GCs. In the DG, CCK neurons form synapses with both GC and PV neurons (Armstrong and Soltesz, 2012; Bartos and Elgueta, 2012) , and we show here that the direct inhibition of CCK neurons reduces the firing of GCs through the increased activity of PV neurons. Chronic SSRI inhibition of GCs through the 5-HT1A receptor has been shown to have an antidepressant effect (Samuels et al., 2015) . Thus, the indirect inhibition of the firing of GCs through PV interneurons seems to be crucial for the acute antidepressant effect, especially since PV neurons do not respond to 5-HT in basal conditions (Y.S., unpublished data). PV neurons play an extremely important and immediate role in the fast modulation of principal neurons in microcircuits and the synchronization of neuronal networks (Hu et al., 2014) , and impairments in function of PV neurons have been widely correlated with several neuropsychiatric diseases (Marín, 2012) . Moreover, it was recently shown that, in a genetic mouse model of depression, abnormal network oscillations leading to the depressive phenotype are caused by defects in fast-spiking PV neurons (Sauer et al., 2015) . The increased GABAergic inhibition of GCs from PV neurons is in line with several reports showing that the antidepressant drugs ultimately lead to enhanced GABA levels in patients in both acute (Bhagwagar et al., 2004) and chronic treatments (Luscher et al., 2011) . These results and the present data strongly suggest that the modulation of interneurons may reflect a mechanism underlying the immediate antidepressant response and that these cell-and receptor-specific approaches may help in the development of fast-acting antidepressants.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: previously described . Chronic treatment with citalopram consisted of 18 days of intraperitoneal injection to alternating sides of the abdomen. After chronic treatment, fluoxetine plasma level was quantified in some animals using high-performance liquid chromatography-tandem mass spectrometry and equally increased level was confirmed in all experimental groups. Acute citalopram (10 mg/kg), fluoxetine (7.5 mg/kg), escitalopram, (10 mg/kg), imipramine, (10 mg/kg), mirtazapine, (10 mg/kg) or saline (as vehicle) were administered intraperitoneally, 15 min before the test.
Slice preparation and electrophysiology
Mice between 8 and 12 weeks of age were euthanized with CO 2 . After decapitation and removal of the brains, transversal slices (400 mm thickness) were cut using a Vibratome 1000 Plus (Leica Microsystems, USA) at 2 C in a NMDG-containing cutting solution (in mM): 105 NMDG (N-Methyl-D-glucamine), 105 HCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 26 NaHCO 3 , 25 Glucose, 10 MgSO 4 , 0.5 CaCl 2 , 5 L-Ascorbic Acid, 3 Sodium Pyruvate, 2 Thiourea (pH was around 7.4, with osmolarity of 295-305 mOsm). After cutting, slices were left to recover for 15 min in the same cutting solution at 35 C and for 1 hr at room temperature (RT) in recording solution (see below). Whole-cell patch-clamp recordings were performed with a Multiclamp 700B/Digidata1550A system (Molecular Devices, Sunnyvale CA, USA). EGFP-positive CCK neurons were selected for recording based on the expression of the fluorescent marker using an upright Olympus BX51WI microscope equipped with the appropriate filters (Olympus, Japan) and a SPECTRA X LED light engine (Lumencor, OR, USA). The extracellular solution used for recordings contained (in mM): 125 NaCl, 25 NaHCO 3 , 2.5 KCl, 1.25 NaH 2 PO 4 , 2 CaCl 2 , 1 MgCl 2 and 25 glucose (bubbled with 95% O 2 and 5% CO 2 ). The slice was placed in a recording chamber (RC-27L, Warner Instruments, USA) and constantly perfused with oxygenated aCSF at 24 C (TC-324B, Warner Instruments, USA) at a rate of 1.5-2.0 ml/min.
For measuring 5-HT or 5-HTRs agonist-induced responses, whole-cell patch-clamp recordings were obtained from GFP-positive CCK neurons using recording pipettes (King Precision Glass, Inc, Glass type 8250) pulled in a horizontal pipette puller (Narishige) to a resistance of 3-4 MU, filled with an internal solution containing (in mM): 126 K-gluconate, 4 NaCl, 1 MgSO 4 , 0.02 CaCl 2 , 0.1 BAPTA, 15 glucose, 5 HEPES, 3 ATP, 0.1 GTP (pH 7.3). 5-HT (30 mM), DOI (20 mM) or CP (10 mM) were applied in the bath using an automatic valve MPS-2 multichannel perfusion system (World Precision Instruments, USA).
Miniature IPSCs were recorded in the presence of CNQX, AP-5 and TTX in a Cl For paired recordings the presynaptic CCK neurons were patched with the intracellular K-gluconate solution while the postsynaptic granule cells were patched using the Cl À rich internal solution. The distance between neurons was between 50 and 100 mm.
Once a stable whole-cell configuration was achieved for both cells, steps of current of 1-2 nA for 2-5 ms were injected in the presynaptic CCK neurons to elicit an action potential. The respective GABAergic response in the granule cells was recorded in the presence of CNQX and AP-5. 50 responses were recorded for each pair of cells and the cells kept for analysis had at least a 20% response rate in a time window of 15 ms following the CCK action potential. Data were acquired at a sampling frequency of 50 kHz and filtered at 1 kHz and analyzed offline using pClamp10 software (Molecular Devices, Sunnyvale, CA, USA). All electrophysiological data are expressed as means ± SEM. Statistical analysis was performed using the Student's t test, One Way Analysis of Variance with Bonferroni post hoc comparison unless stated otherwise, with the help of GraphPad Prism 5. In all experiments, p < 0.05 was considered significant.
In vivo single unit recordings
For unit recordings, animals were anesthetized by intraperitoneal (i.p.) injection of urethane (1mg/kg body weight). For craniotomy, mice were mounted in a stereotaxic frame (David Kopf Instruments), in which the head of the animal was fixed with a pair of ear bars and a perpendicular tooth bar. Body temperature was continuously monitored by a rectal thermometer and maintained at 33 C ± 1 C by placing the animal on a heating pad. Measurements were obtained from the ventral hippocampus, a region specifically involved in mood disorders. Stereotaxic coordinates (in mm, anterioposterior [-2.92 ] measured from bregma; lateral [±2.00] specified from midline;dorsoventral [-2.20 ] from surface of the brain) were set according to the Franklin and Paxinos Mouse Brain atlas (3rd edition). Pipettes used for LFP recordings had tip resistances between 1-3 MOhm. A reference electrode was placed on the skull close to the craniotomy window. Pipettes were gently inserted in the craniotomy window targeting the molecular layer of the dentate gyrus in ventral hippocampus (AP -2.9 mm, L 2 mm, DV -2.2 mm). Positive pressure (100-200 mbar) was applied to avoid pipette plugging. Pipettes contained Indian ink and the position of the electrodes in the hippocampus was evaluated after each experiment. Data were acquired with a Multiclamp 700B/Digidata1550A system (Molecular Devices, Sunnyvale CA, USA).
From the broadband recordings (1 Hz to 10 kHz), we extracted single spike activity and local field potentials (bandpass filter, 1-100 Hz). For the analysis of action potentials, LFP recordings were filtered offline between 300-5000 Hz and spikes were detected with a threshold set sufficiently high above the noise level to avoid artificial triggers by noise peaks (5 X SD). For the spectral analysis at different oscillation frequencies, data were first bandpass filtered at the specific frequency, then the power spectral density was calculated. PSD was estimated separately for each mouse and respective oscillation frequency using 1 s time Hamming windows with a 50% overlap at 1.22 Hz resolution [4096 points/fast Fourier transform (FFT) window]. Analysis was performed with Clampfit (Molecular Devices, USA) and MATLAB Signal Processing Toolbox (Mathworks, USA).
High-density silicone probes recordings
High density silicon probes with 4 shanks were used (Buzsaki32; NeuroNexus Inc.,USA) The shanks were 250 mm apart from each other and bore 8 recording sites each (160 mm 2 each site; 1-3 MU impedance) arranged in a staggered configuration with 20 mm vertical separation. The probes were connected to a RHD 2132 amplifier board with 32 channels (Intan Technologies, USA), mounted on a micromanipulator (Luigs & Neumann, Germany) and lowered into the DG of the urethane-anesthetized mice fixed on a stereotaxic frame (see details above). Data were sampled at 20KHz. After a baseline recording of 20-30 min CNO (1mg/Kg) was injected intraperitoneally.
Spike detection and sorting
For the spike detection the raw recordings were filtered between 800 and 6000 Hz. Candidate spikes were detected on each channel individually as any event negatively deviating from baseline by more than 7 s.d. of the signal. Spikes were then realigned between channels belonging to the same electrode group (the 8 recording sites from the same 'shank' of the silicon probe). Waveforms consisted of 32 data samples (16 before and 16 after the minimal trough of the waveform) for each of the channels of an electrode group. Each 32 points were then projected onto the first 3 principal components of all the detected spikes for a given channel. A waveform was thus characterized by 3 (PC projection) by 8 (number of channel in one electrode group) data points. Spikes from one electrode group from a given session were then clustered in the corresponding 24-dimensional space using KlustaKwik (Harris et al., 2000) . Spike clusters were then manually adjusted using the software Klusters (Hazan et al., 2006) . For the waveform classification spike waveforms were extracted from raw recordings, upsampled to 200kHz and were then bandpass filtered (200-6000 Hz), a broader bandwidth than for spike detection to minimize spike distortion. The waveform of highest amplitude (among all the channels of the electrode group) was averaged and two features were computed: trough-to-peak and half-peak width, two relevant features of the intracellular spikes (McCormick et al., 1985) . Narrow waveform neurons were classified as neurons with half-peak smaller than 0.55ms and trough-to-peak smaller than 0.7ms; wide waveforms were classified as neurons with half peaks longer than 0.6ms and trough-to-peak longer than 0.5ms. Neurons showing narrow waveforms are putative inhibitory interneurons (Barthó et al., 2004; McCormick et al., 1985) . In particular, narrow waveform neurons are likely putative parvalbuminpositive basket cells (Stark et al., 2013) . For the bursting behavior, a cell was considered bursty if the distribution of inter-spike intervals showed a peak between 1.5 and 8 ms.
Chemogenetic/Optogenetic recordings For optogenetic studies, AAV9 coexpressing YFP and Halorhodopsin were injected to the ventral dentate gyrus (vDG, 1 mL to one hemisphere) of mice of 8-12 weeks of age. For chemogenetic studies, rAAV2/hsyn-Dio-hM4D (Gi)-mCherry and control viruses (1 ml/ hemisphere), were bilaterally injected to the ventral dentate gyrus of mice of 8-12 weeks of age. Coordinates for vDG, (for p11, halorhodopsin and DREADD) were ± 2.00, À2.92 and À2.20 mm lateral, posterior and ventral relative to Bregma, according to the Franklin and Paxinos Mouse Brain atlas (3rd edition). For p11 gene delivery, coordinates for vCA1 were: À3.01, À2.92, À2.01, for dCA1: ± 0.50, À1.70, À1.22, and for dDG: ± 0.31, À1.70, À2.20, l.p.v. AAV expressing RFP and either Cre-dependent p11 (2.4 X10 12 U/ml, 1 mL per hemisphere) were a kind gift of Dr. Michael Kaplitt as previously described . The number of subgranular zone CCK cells immunopositive for p11 was vDG, 762 ± 112; vCA1, 611 ± 79; dCA1, 811 ± 142; dDG 708 ± 137. Control mice were treated with YFP expressing viruses. Intraperitoneal clozapine-N-oxide (4 mg/Kg in saline) was injected once daily for 10 days prior to the behavioral test. Animals were perfused after the behavioral studies and the expression of the transgene was confirmed immunohistochemically. For loose cell-attached recordings 2-3 MOhm pipettes filled with an internal K-gluconate solution were gently lowered on the surface of GC or PV neurons recognized by their size, morphology and position in the dentate gyrus layers. A small suction was induced untile the pipette resistance reached a 50 ± 10 MOhm resistance. Recordings in the voltage-clamp mode were performed if the loose cell-attached configuration was maintained for 3-5 min without fluctuations in the resistance. CNO (1 mM) was added to the bath perfusion system and was washed after 15 min of recordings.
Spontaneous IPSCs were recorded in granule cells in the presence of CNQX and AP-5 (to block glutamatergic transmission) in a Cl À rich internal solution (in mM): 126 KCl, 4 NaCl, 1 MgSO4, 0.02 CaCl2, 0.1 BAPTA, 15 Glucose, 5 HEPES, 3 ATP and 0.1 GTP in which the pH was adjusted to 7.3 with KOH and osmolarity was adjusted to 290 mosmol/l with sucrose. Field light stimulation of Haloexpressing CCK or PV neurons was done through a 40x objective using a SPECTRA X LED light engine (Lumencor, OR, USA). Data were acquired at a sampling frequency of 50 kHz, filtered at 1 kHz and analyzed offline using pClamp10 software (Molecular Devices, Sunnyvale, CA, USA).
Statistical analysis
Unless mentioned otherwise, all data are expressed as means ± SEM. Statistical analysis was performed using the Student's t test, One Way Analysis of Variance or Two Way Analysis of Variance with Bonferroni post hoc comparison unless stated otherwise, with the help of GraphPad Prism 5. In all experiments, p < 0.05 was considered significant.
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